Penn Medicine is a Philadelphia-based academic health system and institutional investor that deploys strategic capital through its Co-Investment program to support academic spinouts and healthcare innovation. It backs U.S. companies in early and later-stage venture rounds, with focus areas including biotechnology, life sciences, pharmaceuticals, medical devices, oncology, and healthtech tied to Penn research commercialization and clinical development.